Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Bacil Pharma Ltd (NSE: BACPHAR), ISIN INE711D01018 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
BACPHAR last traded at ₹17.04 (-4.86%), with a 52-week range of ₹10.65 to ₹61.80 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 0.00%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
Data sourced from NSE and BSE filings. Educational — not investment advice.